HMGCR and osteoporosis: It is unclear whether HMG-CoA-reductase inhibition plays a role in the pathogenesis of osteoporosis, but the use of statins has been shown to be effective in patients with osteoporosis combined with cardiovascular and cerebrovascular disease.